Scotland
Kyowa Kirin’s Poteligeo provides progression-free survival in CTCL trial
Kyowa Kirin has reported that the MAVORIC trial of Poteligeo (mogamulizumab) in patients with mycosis fungoides (MF) and Sézary syndrome…
Coronavirus: COVID-19 UK outbreak, measures and impact
Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Coronavirus FAQs Follow the latest updates on coronavirus…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
[ajax_load_more post_type="post" taxonomy="sector" taxonomy_terms="scotland" taxonomy_operator="IN" images_loaded="true" posts_per_page="5" offset="16" pause="true" scroll="false" button_label="View More"]